How Nexopamil racemate can Save You Time, Stress, and Money.
MI-CP151 was a phase 1b randomised, double-blind, placebo controlled, dose-escalation, multicentre analyze To judge numerous intravenous doses of sifalimumab, in adult patients with dermatomyositis or polymyositis (NCT00533091). Major trial goals have been to evaluate the security and tolerability of sifalimumab in dermatomyositis or polymyositis c